Deepak L. Bhatt, M.D., M.P.H., Chairman, Scientific Advisory Board

Dr. Bhatt serves as the Executive Director of Interventional Cardiovascular Programs at Harvard Medical School, affiliated Brigham and Women’s Hospital, and as a Professor at Harvard Medical School. He is the Editor of the Journal of Invasive Cardiology and the Editor-in-Chief of the Harvard Heart Letter for patients. View Biography >>

Paresh N. Soni, M.D., Ph.D., Member, Scientific Advisory Board

Dr. Soni brings 20+ years of experience leading multidisciplinary teams across the entire drug development spectrum. As Head of Development at Amarin, Dr. Soni led the clinical trial and regulatory strategy for Amarin’s natural product fish oil drug Vascepa. View Biography >>

R. Preston Mason, Ph.D., Member, Scientific Advisory Board

Dr. Mason serves on the Faculty of the Department of Medicine, Division of Cardiology, at Harvard Medical School, affiliated Brigham and Women’s Hospital. He has published more than 250 peer reviewed papers, including papers published in collaboration with Cardax, and is a recognized expert on the mechanism of action of astaxanthin and fish oils, particularly Vascepa. View Biography >>